Carl J. Shaar is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of modified growth hormones and their applications. With a total of 3 patents, Shaar's work has had a profound impact on medical science.

Latest Patents

One of Shaar's latest patents is focused on proteins having growth hormone anabolic properties with reduced effects. This specification describes modified growth hormone that retains substantial anabolic potency while significantly diminishing insulin-like and diabetogenic potencies relative to the native hormone. The modified growth hormone features specific structural changes, including the elimination of amino acid residues and cleavage of peptide bonds, which enhance its therapeutic potential. Another significant patent involves the topical use of insulin-like growth factor-II for wound healing. This invention promotes the rate and quality of wound healing by applying IGF-II directly to the wound site, showcasing Shaar's innovative approach to medical treatments.

Career Highlights

Carl J. Shaar has had a distinguished career, working at Eli Lilly and Company, a leading pharmaceutical firm. His research and inventions have contributed to advancements in therapeutic solutions, particularly in the areas of growth hormones and wound healing.

Collaborations

Throughout his career, Shaar has collaborated with esteemed colleagues, including Richard Dennis DiMarchi and Michele C. Smith. These partnerships have fostered a collaborative environment that has led to groundbreaking innovations in biotechnology.

Conclusion

Carl J. Shaar's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence medical science and improve therapeutic options for patients.